Sorted news

Menopause diminishes impact of good cholesterol

What has previously been known as good cholesterol—high density lipoprotein (HDL)—has now been shown to be not so good in protecting women against atherosclerosis while they are transitioning through menopause. That's ...

Oct 08, 2015
popularity17 comments 0

Extended RAS testing urged before EGFR MoAB therapy

(HealthDay)—For patients with metastatic colorectal cancer, anti-epidermal growth factor receptor (EGFR) monoclonal antibody (MoAB) therapy should be considered only after extended RAS testing, according to a study published ...

Oct 08, 2015
popularity3 comments 0